Navigation Links
BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
Date:6/6/2013

Vista CA (PRWEB) June 06, 2013

BioMedical Life Systems, Inc. (http://www.bmls.com) makers of Leading Prescription Pain Relief devices for Medical Professionals, serving the durable medical equipment (DME) dealer and distributor market - for over 30 years, has received FDA clearance to market its newest innovation, the REBOUND™ Health TENS device, without a prescription. This launch catapults the company into the newly emerging medical retail environment and enables this time tested technology to now be available directly to the public.

The REBOUND™ Health is a TENS unit (Transcutaneous Electrical Nerve Stimulator) pain relief device that works “through the skin”, transmitting through electrode pads that are attached to the outside of the skin emitting a “tingling sensation” to help manage pain without the use of drugs. Scientific research suggests that the REBOUND™ Health TENS unit (electro-therapy) can be used to relieve chronic or acute pain by blocking the pain signals and triggering a release of endorphins, which provide natural pain relief.

“This is an amazing development in the effort to provide pain relief alternatives without the use of drugs that may potentially have harmful side effects. BioMedical Life Systems, Inc. has always had the philosophy that the option of drug-free pain relief should be available to everyone. Prior to this FDA clearance, the TENS units were only available with a written prescription. Now, TENS unit technology is finally available over-the-counter. We are pleased to see that the government is recognizing this need for change, and taking the necessary steps to enable wider access to the technology”- Mariah Griffith, Vice President of Sales and Marketing for Biomedical Life Systems, Inc.

The REBOUND™ Health (http://www.reboundpainrelief.com) TENS unit is a compact, extremely durable, portable unit measuring 4.9" x 1.4" x .65”, weighs only 1.3 oz. The TENS device is packaged for retail sale with all necessary accessories. The REBOUND™ TENS unit is Effective and Safe-to-Use for Pain Relief from: Hip, Low Back and Mid-Back Pain, Elbow and Wrist Pain, Shoulder and Arm Pain, Knee Pain, Ankle Pain, Joint and Muscle Pains. Simply Surround Your Pain, Power Up and Go! ™.

For further information:
BioMedical Life Systems, Inc.
PO Box 1360, Vista, CA 92085-1360.
http://www.reboundpainrelief.com
E-mail: information(at)bmls(dot)com
Tel: (Toll Free) 1-800-726-8367
Fax: 760-727-4220

Read the full story at http://www.prweb.com/releases/reboundpainrelief/tensunit/prweb10802657.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
2. Arteriocyte announces Launch of Compass Biomedical
3. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
4. Premier Biomedical CEO Interviewed by The Wall Street Transcript
5. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
6. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
7. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
8. Fourth Annual Bay Area Biomedical Device Conference: March 27th, 2013 at San Jose State University
9. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
10. ABIA Hires Biomedical Executive, Serial Entrepreneur as Chief Operating Officer
11. Market Outlook: The Future of Biomedical Materials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Research and Markets has ... report to their offering. ... The Global Market for Bioproducts ... 2016 at a CAGR of 8.9%, This ... bioproducts into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals ...
(Date:3/23/2017)... LOUISVILLE, Colo. , March 23, 2017  GlobeImmune, ... purchase agreement for the sale of 12,835,490 shares of ... the  NantWorks  ecosystem of companies. In connection with the sale ... GlobeImmune $100,000 in cash and issue to GlobeImmune 200,000 ... common stock. "We are pleased to ...
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare ... personal spirometer and Wellness Management System (WMS), a remote, ... Founded in 2010, PMD Healthcare is a Medical Device, ... a mission dedicated to creating innovative solutions that empower ... With that intent focus, PMD developed the first ever ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
Breaking Biology News(10 mins):